№s4-13 / 2013

V.V. Fomin
Opening remarks
Voznesenskaya T.G.
TREATMENT OF DEPRESSION IN NEUROLOGIC DISEASES
9-13
I.S.Preobrazhenskaya
MILD TO MODERATE COGNITIVE IMPAIRMENT – CLINICAL MANIFESTATIONS, ETIOLOGY, PATHOGENESIS, AND POTENTIALS FOR THE USE
14-18
V.M. Studenikin, V.I. Shelkovsky, L.M. Kuzenkova
TIC DISORDERS AND THE ROLE OF AMINOPHENYL-BUTYRIC ACID IN THEIR TREATMENT
20-24
A.S. Avedisova
OVERCOMING OF NONCOMPLIANCE IN THE THERAPY OF CHRONIC MENTAL ILLNESS
25-30
L.S.Chutko, A.V. Rozhkova, S.Yu. Surushkina
BURNOUT SYNDROME: CLINICAL VARIANTS
31-33
M.V. Ivanov, M.Yu. Shipilin, M.G. Yanushko
SCHIZOPHRENIA AND THE USE OF PSYCHOACTIVE SUBSTANCES: AN APPROACH TO THE DIAGNOSIS AND CHOICE OF ANTIPSYCHOTIC THERAPY
34-38
Yu.E. Azimova, A.N. Magomedova
HEADACHE AND MENTAL DISORDERS: A VIEW OF NEUROLOGIST AND PSYCHIATRIST
39-44
L.S. Chutko, S.Yu. Surushkina
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN
45-48
I.V. Kolykhalov
DONEPEZIL IN THE TREATMENT OF ALZHEIMER'S DISEASE
49-52
N.A. KHITROV
OSTEOARTHROSIS AND OSTEOARTHRITIS - FROM NEW VIEWS OF PATHOGENESIS TO A NEW DENOMINATION
53-58
N.N. Petrova, M.V. Ivanov, M.A. Kaleva, V.M. Chomskaya
EFFICIENCY OF COMBINED ELECTROCONVULSIVE AND NEUROLEPTIC THERAPY IN THE OVERCOMING OF RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA
59-63

Бионика Медиа